vs
ConnectOne Bancorp, Inc.（CNOB）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是ConnectOne Bancorp, Inc.的1.7倍（$197.9M vs $115.6M），ConnectOne Bancorp, Inc.净利率更高（32.7% vs 6.7%，领先26.0%），过去两年ConnectOne Bancorp, Inc.的营收复合增速更高（32.5% vs 14.4%）
原公民共和银行控股公司是公民银行的母公司，总部位于密歇根州弗林特市。该公司曾在密歇根、威斯康星和俄亥俄三州运营219家分行与248台自动取款机，2013年6月与第一美德银行合并，第一美德后于2016年被亨廷顿银行控股收购。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
CNOB vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.7倍
$115.6M
净利率更高
CNOB
高出26.0%
6.7%
两年增速更快
CNOB
近两年复合增速
14.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $115.6M | $197.9M |
| 净利润 | $37.8M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 32.7% | 6.7% |
| 营收同比 | — | 13.6% |
| 净利润同比 | 86.8% | 143.9% |
| 每股收益（稀释后） | $0.72 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CNOBRGEN
| Q1 26 | $115.6M | — | ||
| Q4 25 | $112.6M | $197.9M | ||
| Q3 25 | $121.4M | $188.8M | ||
| Q2 25 | $84.1M | $182.4M | ||
| Q1 25 | $70.2M | $169.2M | ||
| Q4 24 | $68.5M | $174.1M | ||
| Q3 24 | $65.6M | $154.9M | ||
| Q2 24 | $65.8M | $154.1M |
净利润CNOBRGEN
| Q1 26 | $37.8M | — | ||
| Q4 25 | — | $13.3M | ||
| Q3 25 | $41.0M | $14.9M | ||
| Q2 25 | $-20.3M | $14.9M | ||
| Q1 25 | $20.2M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $17.2M | $-654.0K | ||
| Q2 24 | $19.1M | $3.3M |
毛利率CNOBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率CNOBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 47.4% | 9.0% | ||
| Q3 25 | 47.2% | 8.9% | ||
| Q2 25 | -30.1% | 7.6% | ||
| Q1 25 | 39.0% | 3.9% | ||
| Q4 24 | 38.6% | -17.7% | ||
| Q3 24 | 35.3% | -5.1% | ||
| Q2 24 | 39.1% | 1.0% |
净利率CNOBRGEN
| Q1 26 | 32.7% | — | ||
| Q4 25 | — | 6.7% | ||
| Q3 25 | 33.7% | 7.9% | ||
| Q2 25 | -24.1% | 8.2% | ||
| Q1 25 | 28.8% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | 26.2% | -0.4% | ||
| Q2 24 | 28.9% | 2.2% |
每股收益（稀释后）CNOBRGEN
| Q1 26 | $0.72 | — | ||
| Q4 25 | $0.88 | $0.24 | ||
| Q3 25 | $0.78 | $0.26 | ||
| Q2 25 | $-0.52 | $0.26 | ||
| Q1 25 | $0.49 | $0.10 | ||
| Q4 24 | $0.48 | $-0.55 | ||
| Q3 24 | $0.41 | $-0.01 | ||
| Q2 24 | $0.46 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $344.5M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $1.6B | $2.1B |
| 总资产 | $14.2B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资CNOBRGEN
| Q1 26 | $344.5M | — | ||
| Q4 25 | $380.9M | $767.6M | ||
| Q3 25 | $542.7M | $748.7M | ||
| Q2 25 | $596.5M | $708.9M | ||
| Q1 25 | $292.6M | $697.2M | ||
| Q4 24 | $356.5M | $757.4M | ||
| Q3 24 | $247.2M | $784.0M | ||
| Q2 24 | $293.5M | $809.1M |
总债务CNOBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益CNOBRGEN
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $2.1B | ||
| Q3 25 | $1.5B | $2.1B | ||
| Q2 25 | $1.5B | $2.1B | ||
| Q1 25 | $1.3B | $2.0B | ||
| Q4 24 | $1.2B | $2.0B | ||
| Q3 24 | $1.2B | $2.0B | ||
| Q2 24 | $1.2B | $2.0B |
总资产CNOBRGEN
| Q1 26 | $14.2B | — | ||
| Q4 25 | $14.0B | $2.9B | ||
| Q3 25 | $14.0B | $2.9B | ||
| Q2 25 | $13.9B | $2.9B | ||
| Q1 25 | $9.8B | $2.9B | ||
| Q4 24 | $9.9B | $2.8B | ||
| Q3 24 | $9.6B | $2.8B | ||
| Q2 24 | $9.7B | $2.9B |
负债/权益比CNOBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流CNOBRGEN
| Q1 26 | — | — | ||
| Q4 25 | $106.4M | $25.7M | ||
| Q3 25 | $37.4M | $48.1M | ||
| Q2 25 | $6.5M | $28.6M | ||
| Q1 25 | $14.9M | $15.0M | ||
| Q4 24 | $60.7M | $39.2M | ||
| Q3 24 | $-14.4M | $49.3M | ||
| Q2 24 | $22.3M | $42.2M |
自由现金流CNOBRGEN
| Q1 26 | — | — | ||
| Q4 25 | $101.0M | $17.6M | ||
| Q3 25 | $33.9M | $43.4M | ||
| Q2 25 | $6.4M | $21.5M | ||
| Q1 25 | $14.6M | $11.4M | ||
| Q4 24 | $56.9M | $33.6M | ||
| Q3 24 | $-15.6M | $42.3M | ||
| Q2 24 | $22.2M | $37.4M |
自由现金流率CNOBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 89.7% | 8.9% | ||
| Q3 25 | 27.9% | 23.0% | ||
| Q2 25 | 7.6% | 11.8% | ||
| Q1 25 | 20.8% | 6.8% | ||
| Q4 24 | 83.1% | 19.3% | ||
| Q3 24 | -23.8% | 27.3% | ||
| Q2 24 | 33.7% | 24.3% |
资本支出强度CNOBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 4.8% | 4.1% | ||
| Q3 25 | 2.8% | 2.5% | ||
| Q2 25 | 0.1% | 3.9% | ||
| Q1 25 | 0.4% | 2.1% | ||
| Q4 24 | 5.5% | 3.2% | ||
| Q3 24 | 1.9% | 4.5% | ||
| Q2 24 | 0.2% | 3.1% |
现金转化率CNOBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 1.93× | ||
| Q3 25 | 0.91× | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | 0.74× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.84× | — | ||
| Q2 24 | 1.17× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CNOB
| Net Interest Income | $108.8M | 94% |
| Noninterest Income | $6.8M | 6% |
RGEN
暂无分部数据
